Givaudan successfully acquired Alderys to expand natural flavors
On August 3, Givaudan announced on its official website that it has completed the acquisition of Alderys, a French flavor, fragrance and cosmetic raw material biotechnology company.
Founded in 2009, Alderys is a French biotechnology company headquartered in Orsay and currently has 30 employees. The company is committed to developing innovative bioengineering approaches to produce high-value compounds from renewable raw materials. Its research and development projects aim to serve the chemical, cosmetics and nutrition industries. Alderys is well-recognized in the industry due to its innovative technological industrial solutions reaching high sustainability standards.
Givaudan Fragrance Division President Maurizio Volpi (Maurizio Volpi) said: Their biotechnology expertise fits perfectly with our fragrance and active beauty business. Thanks to their powerful bioengineering research and development platform, we can expand the natural and biological product portfolio.
Alderys CEO Dominique Thomas expressed pride in joining Givaudan and emphasized that the company will continue to serve new and existing customers as an independent entity in the Givaudan family.
Although the terms of the transaction were not disclosed, on an assumption, Alderys' business could add 3 million Euros to Givaudan's performance in 2019.
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
Brenntag Partners with Givaudan to Supply Active Cosmetic Ingredients and Raw Materials to Thailand
-
Givaudan Invests $215 Million in Ohio for Liquid Production Facility
-
Givaudan Breaks Ground on New Fragrance Factory in Guangzhou
-
Givaudan Introduces New Labdanum Absolute for Fragrance Creations
-
Givaudan Acquires Majority Stake in Brazil's Vollmens
-
Givaudan expands encapsulation technology production capacity in Mexico
-
Givaudan increases encapsulation technology capacity in Mexico
-
Givaudan opens collaborative high-end fragrance center in China
Recommend Reading
-
Azelis Strengthens Partnership with SI Group, Becoming Its New Distributor of Plastic Additives
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
Unilever Sells Kate Somerville Brand to Rare Beauty Brands
-
ExxonMobil Shuts Another Singapore Facility: The Global Petrochemical Shake-Up Leaves No Easy Winners
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
This Week, China's Titanium Dioxide Market Remains Stable (9.8-9.12)
-
Fundamentals Remain Stable as Aniline Market Continues to Stabilize
-
Optimistic Expectations for US-Iran Talks Lead to Sharp Drop in Oil Prices, Long-term Supply and Demand Dynamics Remain Uncertain
-
Ethyl Acetate Prices Continue to Decline
-
Acetic Acid Market Trends Consolidate (May 18–May 24)